Suchergebnisse - "145155-23-3"

PubPharm (1.030)

41

Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain

enthalten in: AIDS (London, England) | 2020

von Molina-Iturritza, E. | San-José-Muñiz, I. | Ganchegui-Aguirre, M. | +4

42

Five severe COVID-19 pneumonia patients treated with triple combination therapy with lopinavir/ritonavir, hydroxychloroquine, and interferon β-1b

enthalten in: International journal of antimicrobial agents | 2020

von Hong, S. | Ryu, B. | Chong, Y. | +6

43

A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis

enthalten in: Advances in clinical and experimental medicine : official organ Wroclaw Medical University | 2020

von Pietrzak, A. | Kalinowska-Łyszczarz, A. | Osztynowicz, K. | +3

44

Sequential adaptive variables and subject selection for GEE methods

enthalten in: Biometrics | 2020

von Chen, Z. | Wang, Z. | Chang, Y.

45

Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19 : structured summary of a study protocol for a randomized controlled trial

enthalten in: Trials | 2020

von Irvani, S. | Golmohammadi, M. | Pourhoseingholi, M. | +2

46

The rationale for Low-Molecular Weight Heparin (LMWH) use in SARS-CoV-2 infection

enthalten in: Le infezioni in medicina | 2020

von Di Perri, G.

47

Interferon beta-1b for COVID-19

enthalten in: Lancet (London, England) | 2020

von Shalhoub, S.

CommentOn: Lancet. 2020 May 30;395(10238):1695-1704. - PMID 32401715

48

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2020

von Hung, I. | Lung, K. | Tso, E. | +41

CommentIn: Lancet. 2020 May 30;395(10238):1670-1671. - PMID 32401712

49

Vitamin D, smoking, EBV, and long-term cognitive performance in MS : 11-year follow-up of BENEFIT

enthalten in: Neurology | 2020

von Cortese, M. | Munger, K. | Martínez-Lapiscina, E. | +115

CommentIn: Neurology. 2020 May 5;94(18):771-772. - PMID 32300061

50

Active Pulmonary Tuberculosis Triggered by Interferon Beta-1b Therapy of Multiple Sclerosis : Four Case Reports and a Literature Review

enthalten in: Medicina (Kaunas, Lithuania) | 2020

von Sirbu, C. | Dantes, E. | Plesa, C. | +2